The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121777554 12177755 4 F 20160112 20160704 20160314 20160718 EXP NL-TEVA-630763ISR TEVA 65.86 YR M Y 0.00000 20160718 MD NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121777554 12177755 1 SS lonquex LIPEGFILGRASTIM 1 Unknown Y UNKNOWN 0
121777554 12177755 2 PS DOXORUBICIN DOXORUBICIN 1 100 MILLIGRAM DAILY; 63097
121777554 12177755 3 SS VINCRISTINE VINCRISTINE 1 2 MILLIGRAM DAILY; 75493
121777554 12177755 4 SS PREDNISOLONE. PREDNISOLONE 1 500 MILLIGRAM DAILY; 89081
121777554 12177755 5 SS Rituximab RITUXIMAB 1 700 MILLIGRAM DAILY; 0
121777554 12177755 6 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 1447 MILLIGRAM DAILY; 0
121777554 12177755 7 C FENTANYL. FENTANYL 1 0
121777554 12177755 8 C Dormicum MIDAZOLAMMIDAZOLAM HYDROCHLORIDE 1 0
121777554 12177755 9 C INSUMAN INSULIN HUMAN 1 0
121777554 12177755 10 C GANCICLOVIR. GANCICLOVIR 1 800 MILLIGRAM DAILY; 0 400 MG BID
121777554 12177755 11 C Caspofungine 2 70 MG ON DAY 1 AND THEN 50 MG DAILY 0
121777554 12177755 12 C Ciproxin CIPROFLOXACIN 1 1200 MILLIGRAM DAILY; 0 400 MG TID
121777554 12177755 13 C Imipenem/Celastatine 2 4000 MILLIGRAM DAILY; 0 1000 MG QID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121777554 12177755 2 Chemotherapy
121777554 12177755 3 Chemotherapy
121777554 12177755 4 Chemotherapy
121777554 12177755 5 Chemotherapy
121777554 12177755 6 Chemotherapy
121777554 12177755 7 Chemotherapy
121777554 12177755 8 Chemotherapy
121777554 12177755 9 Chemotherapy
121777554 12177755 10 Chemotherapy
121777554 12177755 11 Chemotherapy
121777554 12177755 12 Chemotherapy
121777554 12177755 13 Chemotherapy

Outcome of event

Event ID CASEID OUTC COD
121777554 12177755 LT
121777554 12177755 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
121777554 12177755 Anaemia
121777554 12177755 Bacteraemia
121777554 12177755 Blood sodium increased
121777554 12177755 Diabetes mellitus
121777554 12177755 Dyspnoea
121777554 12177755 Hyperkalaemia
121777554 12177755 Impaired gastric emptying
121777554 12177755 Neutropenia
121777554 12177755 Oedema
121777554 12177755 Pneumonia
121777554 12177755 Tachycardia
121777554 12177755 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121777554 12177755 1 20160113 0
121777554 12177755 2 20160112 20160112 0
121777554 12177755 3 20160112 20160112 0
121777554 12177755 4 20160112 20160116 0
121777554 12177755 5 20160112 20160112 0
121777554 12177755 6 20160112 20160112 0
121777554 12177755 10 20160112 0
121777554 12177755 11 20160112 0
121777554 12177755 12 20160112 0
121777554 12177755 13 20160112 0